Abandoning clinical trial safeguards won't boost local industry

Authors

Paul Komesaroff, Monash University
Colin J. H Thomson, University of WollongongFollow
Ian Kerridge, University of Sydney

RIS ID

91669

Publication Details

Komesaroff, P., Thomson, C. & Kerridge, I. (2013). Abandoning clinical trial safeguards won't boost local industry. The Conversation, 7 October 1-4.

Link to publisher version (URL)

The Conversation

Abstract

CLINICAL TRIALS - Human clinical trials are an important last hurdle in the development of new drugs and therapies. Today, The Conversation takes a closer look at this vital scientific endeavour with three articles that look at different aspects of the process.